Cigna ratings upgraded by Fitch as leverage improves

Cigna ratings upgraded by Fitch as leverage improves
Cigna ratings upgraded by Fitch

The Cigna Group's credit profile strengthened as Fitch Ratings raised its holding company Issuer Default Ratings and senior unsecured debt ratings to 'A-' from 'BBB+'. The agency kept the insurer financial strength ratings of Cigna's operating subsidiaries at 'A+' with a stable outlook, citing scale, diversification and stronger leverage metrics.

Highlights

  • Cigna's holding company ratings upgraded by Fitch due to improved financial leverage, with debt-to-EBITDA projected at 2.3x by September 30, 2026, down from 2.5x at 2024 year-end.
  • Fitch expects Cigna's operating EBITDA margins to decrease from 6% (2019-2023 average) to 5.2% in 2024 and 4.7% in 2025, mainly due to higher medical costs and lower-margin contracts.
  • NAIC risk-based capital ratio estimated at 230% at year-end 2025, down from 259% a year earlier, with moderate strengthening anticipated in 2026.

Rating action reflects stronger balance sheet

As reported by Fitch Ratings, the upgrade of Cigna's holding company ratings follows improvement in recent years in financial leverage, particularly as measured by debt-to-EBITDA. Fitch says the company's financial profile is now at a level that no longer warrants an additional notch between the insurer financial strength ratings and the holding company Issuer Default Ratings.

Fitch also affirms Cigna's short-term debt ratings and Short-Term IDR at 'F2'. The agency says the affirmation of the operating subsidiaries' insurer financial strength ratings reflects Cigna's large operating scale, strong competitive position and diversification across geography and business lines, although modest margin pressure in recent years partly offsets those strengths.

Cigna's business profile is supported by its two main segments, Evernorth Health Services and Cigna Healthcare. Fitch says Evernorth adds scale, differentiated capabilities and material unregulated cash flows, while the combined structure improves Cigna's ability to compete with larger peers that have significant non-health insurance operations.

Margins and capital remain key rating factors

Fitch says Cigna's historical operating performance has been strong, with operating EBITDA margins averaging about 6% during the three years ended Dec. 31, 2023. Margin pressure in 2024 and 2025 lowers estimated operating EBITDA margins to about 5.2% and 4.7%, respectively, mainly because of higher-than-expected medical costs in stop-loss products and the onboarding or renewal of lower-margin pharmacy benefit manager contracts.

The agency says margins improve in Cigna Healthcare in 2026, while pharmacy benefit services margins remain somewhat pressured. Fitch estimates return on capital averaged about 8.2% during the three years ended Dec. 31, 2025, in line with its 'a+' financial performance and earnings guidelines, and places greater weight on return on capital because of Evernorth's growing share of the group's operations.

At Sept. 30, 2026, Fitch says Cigna's financial leverage ratio is about 39% and debt-to-operating EBITDA is 2.3x, compared with 42% and 2.5x at year-end 2024. The agency estimates the NAIC risk-based capital ratio at about 230% of the Company Action Level on a combined basis at year-end 2025, down from 259% a year earlier, and expects moderate strengthening in 2026.

Fitch says Cigna's low exposure to government-funded business limits its exposure to pressures in Medicare Advantage and Medicaid. For future rating actions, the agency says negative pressure could emerge from sustained RBC ratios below 235%, return on capital below 7.5%, or debt-to-EBITDA above 3.0x with leverage above 45%, while positive action could follow sustained return on capital of 9% or higher, debt-to-EBITDA of 1.8x and leverage of 38% or lower, and RBC above 275%.

This adds to earlier discussion around CNA Financial ratings affirmed by Fitch with a stable outlook tied to capital and underwriting fundamentals.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.